Dabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin

Published 2010 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Dabigatran: An Oral Novel Potent Reversible Nonpeptide Inhibitor of Thrombin
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 30, Issue 10, Pages 1885-1889
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-07-30
DOI
10.1161/atvbaha.110.203604

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.